Open-Label Extension Study of Kuvan for Autism
Condition(s):Autistic DisorderLast Updated:May 2, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Autistic DisorderLast Updated:May 2, 2018Completed
Condition(s):Hypertension,EssentialLast Updated:July 12, 2019Completed
Condition(s):PhenylketonuriaLast Updated:April 13, 2006Completed
Condition(s):PhenylketonuriaLast Updated:January 4, 2018Completed
Condition(s):Autism Spectrum DisorderLast Updated:April 1, 2014Completed
Condition(s):PhenylketonuriaLast Updated:April 24, 2023Completed
Condition(s):Tetrahydrobiopterin Deficiencies; Hyperphenylalaninemia, Non-PhenylketonuricLast Updated:September 25, 2020Completed
Condition(s):Phenylalanine Hydroxylase DeficienciesLast Updated:September 20, 2007Terminated
Condition(s):Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or Tetrahydrobiopterin (BH4) DeficiencyLast Updated:April 15, 2022Completed
Condition(s):PhenylketonuriaLast Updated:December 3, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.